BNP/Troponin Dual Elevation Index Calculator
Biomarker threshold calculator
Enter biomarker concentrations and the relevant thresholds to count how many thresholds are exceeded.
0–2Count
Clinical caution: The original low/intermediate/high-risk interpretation has not been verified as a validated prediction rule. Do not use this count alone to diagnose acute coronary syndrome, myocardial infarction, or acute heart failure, or to determine disposition or treatment.
Clinical context and limitations
BNP and cardiac troponin provide different clinical information. BNP is used in the evaluation of suspected heart failure, while cardiac troponin is used to assess myocardial injury. An elevation in either biomarker is not specific to a single diagnosis.
How the count is calculated
- One point is counted when BNP is strictly greater than the BNP threshold entered.
- One point is counted when troponin is strictly greater than the entered upper reference limit.
- The result is the arithmetic sum, from 0 to 2. A value exactly equal to a threshold does not count as above it.
Important interpretation points
- The 400 pg/mL BNP threshold and 14 ng/L troponin threshold are inherited defaults from the original code, not universal diagnostic or prognostic thresholds.
- Troponin assays are not interchangeable; use the appropriate laboratory-specific 99th-percentile upper reference limit and consider serial changes and clinical context.
- Myocardial infarction requires evidence of acute myocardial injury together with clinical evidence of acute myocardial ischemia. Biomarker elevation alone is insufficient.
References
Thygesen K, Alpert JS, Jaffe AS, et al.
Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138:e618–e651. This consensus document supports assay-specific troponin interpretation and the distinction between myocardial injury and myocardial infarction.
doi:10.1161/CIR.0000000000000617
Maisel et al. reference in the original file
The supplied citation titled “Combined B-type Natriuretic Peptide and Troponin Elevation in Acute Heart Failure: Risk Stratification and Prognostic Implications” could not be independently verified in the supplied bibliographic form and is therefore not used to validate the index or its risk categories.
Disclaimer: This tool performs a simple arithmetic threshold count and is not a validated clinical prediction model. It does not replace clinical assessment, assay-specific laboratory guidance, ECG findings, serial biomarker testing, imaging, or applicable clinical guidelines.
PERSONAL WORKSPACE
Clinical notes
Document key findings and keep a structured record for your own reference.
Private by design. Notes are stored in this browser on this device only. They are not uploaded to Appcardio.
Export or share this note
PERSONAL WORKSPACE
My notes
Review, edit, or remove notes saved in this browser.
Stored locally on this device
QUALITY & SAFETY
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.
Please describe the issue clearly. For calculation concerns, include the input values and expected result where possible.